Finding the sweet spot in managing diabetes with coronary artery disease and chronic kidney disease: Pharmacotherapy pearls with a focus on sodium-glucose cotransporter-2 inhibitors.
Year: 2020
Type: article
Abstract: In the past decade, the availability of newer glucose-lowering medications has offered more options for achieving glycemic targets in adults living with type 2 diabetes mellitus (T2DM). However, with more options comes the challenge of considering the clinical benefits, harms, and practical issues
Source: PubMed Central
Authors: Taisa Trischuk, Tessa Laubscher, Loren Regier
Institution: University of Saskatchewan
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W3024092020